医学
心房颤动
心脏病学
心包液
导管消融
染色
心包积液
病理
内科学
作者
Takamitsu Takagi,Thomas Pambrun,Takashi Nakashima,Konstantinos Vlachos,Clémentine André,Philipp Krisai,F. Daniel Ramirez,Tsukasa Kamakura,Yosuke Nakatani,Ghassen Cheniti,Romain Tixier,Remi Chauvel,Josselin Duchateau,Frederic Sacher,Hubert Cochet,Mélèze Hocini,Michel Haïssaguerre,Pierre Jaïs,Nicolas Derval
出处
期刊:Heart Rhythm
[Elsevier]
日期:2021-07-01
卷期号:18 (7): 1057-1063
被引量:1
标识
DOI:10.1016/j.hrthm.2021.03.023
摘要
Localized staining due to venule injury is attributable to ethanol infusion into the vein of Marshall (Et-VOM).The purpose of this study was to investigate adverse outcomes of localized staining during Et-VOM in patients undergoing ablation for atrial fibrillation.Two hundred four patients (age 64 ± 10 years; 153 male) were sorted based on the aspect of localized staining. Staining of atrial myocardium that spread uniformly along the VOM vascular tree following selective VOM venography was considered normal, in contrast to predominantly localized staining that spread concentrically from a focal point due to vascular injury. Outcomes between the 2 groups were compared.Localized staining was observed in 27% of patients. No patients developed clinically significant pericardial effusions during Et-VOM; however, 7 patients developed pericardial effusions on the first postprocedural day (3.6% in patients with vs 3.4% in patients without localized staining). No significant difference was found in achievement of acute mitral isthmus (MI) block (96% vs 98%) and size of the endocardial low-voltage area (8.5 ± 4.1 cm2 vs 9.3 ± 5.3 cm2) in patients with and without localized staining, respectively. Long-term follow-up was not impacted by localized staining. Freedom from recurrent atrial tachyarrhythmias (66% vs 76%) and durability of MI block (57% vs 54%) were not significantly different with and without localized staining. There were no cases of rehospitalization for pericarditis, chronic pericardial effusion, or heart failure.In our study, localized staining was frequent but was not associated with clinically relevant impact or disadvantages.
科研通智能强力驱动
Strongly Powered by AbleSci AI